Anti-inflammatory therapy for repeated stent blockages
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if anti-inflammatory drugs like prednisone or colchicine can prevent stents from blocking again in people who have already had multiple stent blockages. It may offer a new treatment option for those with recurrent in-stent restenosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have coronary artery disease.
- You have had at least one stent that has blocked again two or more times.
- You are planning to have a procedure to reopen that blocked stent.
- You can take standard heart medications, including blood thinners and statins.
- You are willing to sign a consent form and complete follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests combining two medicines (sirolimus and corticosteroids) to treat a specific type of heart stent blockage that keeps coming back. It aims to reduce the chance of the artery narrowing again after a recent procedure to open it.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
This study tests whether the drug colchicine can reduce inflammation in people with coronary heart disease who have had a stent placed. It aims to see if colchicine helps improve heart health by lowering inflammation.
Hear when a new In-stent Restenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.